Skip to main content

Advertisement

Log in

Comments on the eighth edition of the TNM classification for lung cancer. Radical changes and limitations: Does size matter?

  • Thoracic Oncology
  • Published:
Hellenic Journal of Surgery

Abstract

Aim-Background

Cancer is a major public health problem worldwide and the second leading cause of death in the United States of America (USA), following heart disease. Male lung cancer death rates are decreasing in the western world and increasing in China and several other countries in Asia and Africa. Female lung cancer death rates are increasing worldwide, with the exception of the USA, Canada and Australia. Differences in lung cancer incidence patterns between men and women reflect historical differences in tobacco use. Staging of cancer at the time of diagnosis is the most important predictor of survival, and treatment options should be based on the stage. The aim of this overview is to discuss the changes in the 8th Edition of the TNM (Tumor, Nodes, Metastasis) Classification of lung cancer and its impact on predicting patient prognosis. Potential limitations of the classification system and future directions are discussed.

Methods

A systematic literature search was performed to identify relevant reports. Studies and articles were identified using several online searches of the U.S. National Library of Medicine via www.pubmed.com. The article is based on the International Association for the Study of Lung Cancer (IASLC) Staging and Prognostic Factors Committee report. An international lung cancer database was developed from 35 sources in 16 countries around the globe, with staging and outcome data on 94,708 cases of lung cancer.

Result

This new edition of lung cancer TNM staging placed additional emphasis on tumor size, and size cut-off points have been added, which will now be a descriptor in all TNM categories. For the first time a new term was introduced, defined as minimally invasive adenocarcinoma. The additional cut-off point changes will definitely alter treatment recommendations in the future. The node classification remained unchanged in the new edition. Regarding metastasis, M1a refers to cases with intrathoracic metastases, M1b cases with a single metastasis outside the thoracic cavity. The situation involving multiple metastatic deposits, usually in more than one organ, is now classified as M1c.

Conclusions

The new staging of lung cancer is based on analysis of survival in large databases, based on tumor size and disease proliferation, and is therefore expected to assess the prognosis of the individual patient more accurately. Based on the current edition of the TNM staging system many patients will be given a different staging category,. It is evident that improved survival may reflect the expected improvements in diagnosis and treatment, the net effect being a stage-for-stage survival increase at all stages. This 8th edition of the TNM classification for lung cancer has placed additional emphasis on tumor size.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2016. CA Cancer J Clin 2016;66:7–30.

    Article  PubMed  Google Scholar 

  2. Harris JE. Cigarette smoking among successive birth cohorts of men and women in the United States during 1900-80. J Natl Cancer Inst 1983;71:473–9.

    CAS  PubMed  Google Scholar 

  3. Jemal A, Ma J, Rosenberg PS, et al. Increasing lung cancer death rates among young women in southern and midwestern states. J Clin Oncol 2012;30:2739–44.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Aberle DR, Adams AM, et al. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with lowdose computed tomographic screening. N Engl J Med 2011;365:395–409.

    Article  PubMed  Google Scholar 

  5. Welch HG, Schwartz LM, Woloshin S. Are increasing 5-year survival rates evidence of success against cancer? JAMA 2000;283:2975–8.

    Article  CAS  PubMed  Google Scholar 

  6. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2012. Bethesda, MD: National Cancer Institute; 2015.

    Google Scholar 

  7. Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008;100:1672–94.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Holford TR, MezaR, WarnerKE, et al. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. JAMA 2014;311:164–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. US Department of Health and Human Services. The Health Consequences of Smoking 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.

    Google Scholar 

  10. Siegel RL, Jacobs EJ, Newton CC, et al. Deaths due to cigarette smoking for 12 smoking-related cancers in the United States. JAMA Intern Med 2015;175:1574–6.

    Article  PubMed  Google Scholar 

  11. Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 2009;15:4–9.

    PubMed  Google Scholar 

  12. Mirsadraee S, Oswal D, Alizadeh Y, et al. The 7th lung cancer TNM classification and staging system: Review of the changes and implications. World J Radiol 2012;4:128–34.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Rami-Porta R, Bolejack V, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 2015;10:990–1003.

    Article  PubMed  Google Scholar 

  14. Eberhardt WEE, Mitchell A, Crowley J, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the M descriptors in the forthcoming (8th) edition of the TNM classification of lung cancer. J Thorac Oncol 2015;10:1515–22.

    Article  PubMed  Google Scholar 

  15. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718–23.

    Article  CAS  PubMed  Google Scholar 

  16. Toloza EM, Harpole L, Detterbeck F, et al. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003;123:157S–166S.

    Article  PubMed  Google Scholar 

  17. Luke WP, Pearson FG, Todd TR, et al. Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung. J Thorac Cardiovasc Surg 1986;91:53–6.

    CAS  PubMed  Google Scholar 

  18. Coughlin M, Deslauriers J, Beaulieu M, et al. Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer. Ann Thorac Surg 1985;40:556–60.

    Article  CAS  PubMed  Google Scholar 

  19. Ømark Petersen H, Eckardt J, Hakami A, et al. The value of mediastinal staging with endobronchial ultrasound-guided transbronchial needle aspiration in patients with lung cancer. Eur J Cardiothorac Surg 2009;36:465–8.

    Article  PubMed  Google Scholar 

  20. Rintoul RC, Skwarski KM, Murchison JT, et al. Endobronchial and endoscopic ultrasound-guided real-time fine-needle aspiration for mediastinal staging. Eur Respir J 2005;25:416–21.

    Article  CAS  PubMed  Google Scholar 

  21. Wallace MB, Pascual JM, Raimondo M, et al. Minimally invasive endoscopic staging of suspected lung cancer. JAMA 2008;299:540–6.

    Article  CAS  PubMed  Google Scholar 

  22. Nikolouzos S, Zacharia G, Charpidou A, et al. Invasive Techniques in Diagnosis and Staging of Lung Cancer. Hellenic J Surg 2014;86:129–36.

    Article  Google Scholar 

  23. Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project: Proposals for revision of the TNM Stage Groupings in the Forthcoming (8th) Edition of the TNM Classification for Lung Cancer. Journal of Thoracic Oncology 2016;11:39–51.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Nikolouzos.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nikolouzos, S., Zacharia, G., Baltayiannis, N. et al. Comments on the eighth edition of the TNM classification for lung cancer. Radical changes and limitations: Does size matter?. Hellenic J Surg 89, 141–148 (2017). https://doi.org/10.1007/s13126-017-0401-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13126-017-0401-7

Key words

Navigation